semaglutide criteria for use Two-year effects of in adults with overweight or obesity: the STEP 5 trial How To Qualify for Semaglutide:

Am Heart J 1(227):5663 Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP et al (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Get in touch Are you at your heaviest weight

The trial, which began in October 2018, was originally designed to test the hypothesis that semaglutide could protect nondiabetic patients with metabolic syndrome, a condition characterized by excess body fat and insulin resistance, from cardiovascular events

1 Year of Semaglutide vs